EGF and hepatocellular carcinoma: The continuous activation of EGF-EGFR signalling pathway is considered as a key factor in inflammation and modulated tumour proliferation, differentiation, epithelial–mesenchymal transition and angiogenesis within HCC 26–28, although the mechanism by which EGF regulates the occurrence of inflammatory microenvironment remains unclear.